The global Thyrogen and Biosimilar market was valued at US$ 264.4 million in 2022 and is projected to reach US$ 703.3 million by 2029, at a CAGR of 15.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Thyrogen and Biosimilar include Sanofi and Sato Pharmaceutical etc. in 2022, the global top five players have a share approximately % in terms of revenue.
THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line.
This report aims to provide a comprehensive presentation of the global market for Thyrogen and Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyrogen and Biosimilar. This report contains market size and forecasts of Thyrogen and Biosimilar in global, including the following market information:
Global Thyrogen and Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Thyrogen and Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Thyrogen and Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thyrogen and Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thyrogen and Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Thyrogen and Biosimilar Market Segment Percentages, by Type, 2022 (%)
Brand
Biosimilar
Global Thyrogen and Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Thyrogen and Biosimilar Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Other
Global Thyrogen and Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Thyrogen and Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thyrogen and Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Thyrogen and Biosimilar revenues share in global market, 2022 (%)
Key companies Thyrogen and Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Thyrogen and Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Sato Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thyrogen and Biosimilar, market overview.
Chapter 2: Global Thyrogen and Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Thyrogen and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thyrogen and Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Thyrogen and Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Thyrogen and Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Thyrogen and Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Thyrogen and Biosimilar Overall Market Size
2.1 Global Thyrogen and Biosimilar Market Size: 2022 VS 2029
2.2 Global Thyrogen and Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Thyrogen and Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Thyrogen and Biosimilar Players in Global Market
3.2 Top Global Thyrogen and Biosimilar Companies Ranked by Revenue
3.3 Global Thyrogen and Biosimilar Revenue by Companies
3.4 Global Thyrogen and Biosimilar Sales by Companies
3.5 Global Thyrogen and Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Thyrogen and Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Thyrogen and Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Thyrogen and Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Thyrogen and Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Thyrogen and Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Thyrogen and Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Brand
4.1.3 Biosimilar
4.2 By Type - Global Thyrogen and Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Thyrogen and Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Thyrogen and Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Thyrogen and Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Thyrogen and Biosimilar Sales & Forecasts
4.3.1 By Type - Global Thyrogen and Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Thyrogen and Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Thyrogen and Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Thyrogen and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Thyrogen and Biosimilar Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Thyrogen and Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Thyrogen and Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Thyrogen and Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Thyrogen and Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Thyrogen and Biosimilar Sales & Forecasts
5.3.1 By Application - Global Thyrogen and Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Thyrogen and Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Thyrogen and Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Thyrogen and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Thyrogen and Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Thyrogen and Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Thyrogen and Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Thyrogen and Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Thyrogen and Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Thyrogen and Biosimilar Sales & Forecasts
6.3.1 By Region - Global Thyrogen and Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Thyrogen and Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Thyrogen and Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Thyrogen and Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Thyrogen and Biosimilar Sales, 2018-2029
6.4.3 US Thyrogen and Biosimilar Market Size, 2018-2029
6.4.4 Canada Thyrogen and Biosimilar Market Size, 2018-2029
6.4.5 Mexico Thyrogen and Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Thyrogen and Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Thyrogen and Biosimilar Sales, 2018-2029
6.5.3 Germany Thyrogen and Biosimilar Market Size, 2018-2029
6.5.4 France Thyrogen and Biosimilar Market Size, 2018-2029
6.5.5 U.K. Thyrogen and Biosimilar Market Size, 2018-2029
6.5.6 Italy Thyrogen and Biosimilar Market Size, 2018-2029
6.5.7 Russia Thyrogen and Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Thyrogen and Biosimilar Market Size, 2018-2029
6.5.9 Benelux Thyrogen and Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Thyrogen and Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Thyrogen and Biosimilar Sales, 2018-2029
6.6.3 China Thyrogen and Biosimilar Market Size, 2018-2029
6.6.4 Japan Thyrogen and Biosimilar Market Size, 2018-2029
6.6.5 South Korea Thyrogen and Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Thyrogen and Biosimilar Market Size, 2018-2029
6.6.7 India Thyrogen and Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Thyrogen and Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Thyrogen and Biosimilar Sales, 2018-2029
6.7.3 Brazil Thyrogen and Biosimilar Market Size, 2018-2029
6.7.4 Argentina Thyrogen and Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Thyrogen and Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Thyrogen and Biosimilar Sales, 2018-2029
6.8.3 Turkey Thyrogen and Biosimilar Market Size, 2018-2029
6.8.4 Israel Thyrogen and Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Thyrogen and Biosimilar Market Size, 2018-2029
6.8.6 UAE Thyrogen and Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Thyrogen and Biosimilar Major Product Offerings
7.1.4 Sanofi Thyrogen and Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Sato Pharmaceutical
7.2.1 Sato Pharmaceutical Company Summary
7.2.2 Sato Pharmaceutical Business Overview
7.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Major Product Offerings
7.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Sato Pharmaceutical Key News & Latest Developments
8 Global Thyrogen and Biosimilar Production Capacity, Analysis
8.1 Global Thyrogen and Biosimilar Production Capacity, 2018-2029
8.2 Thyrogen and Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Thyrogen and Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Thyrogen and Biosimilar Supply Chain Analysis
10.1 Thyrogen and Biosimilar Industry Value Chain
10.2 Thyrogen and Biosimilar Upstream Market
10.3 Thyrogen and Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Thyrogen and Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report